Status:
COMPLETED
RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
Up to 1 years
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in RNA and identify biomarkers related to cancer. PURPOSE: This ...
Detailed Description
OBJECTIVES: * Sequence the microRNAs present in 20 infant AML samples as a pilot study. * Compare microRNAs present in infant AML samples to infant ALL samples that are being concurrently sequenced i...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of acute myeloid leukemia
- Available cryopreserved cells from diagnosis
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01229124
Start Date
October 1 2010
End Date
May 1 2016
Last Update
May 17 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.